Cotización Petros Pharmaceuticals - PTPI

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

0.2565

Postura de Compra

0.25

Postura de Venta

0.2565

Volume Operado de la Acción

315,266

0.232 Rango del Día 0.265

0.2208 Rango de 52 semanas 2.27

Capitalización de Mercado [m]

2.569M

Precio Anterior

0.2473

Precio de Apertura

0.265

Hora

0.2565

Última hora de negociación

Volumen financiero

US$ 77,590

Precio Promedio Ponderado

0.24611

Volumen promedio (3 m)

174,605

Acciones en circulación

10,014,872

Rendimiento del Dividendo

Ratio Precio/Utilidad

-0.19

Beneficio por acción (BPA)

-1.38

turnover

5.82M

Beneficio neto

-13.81M

Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's ope... Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Prescription Medications segment. The Prescription Medications segment consists primarily of operations related to Stendra, which is sold generally in the United States, and H100 for the treatment of Peyronie's disease. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.petrospharma.com

Sede

Wilmington, Delaware, USA

Fundado

Petros Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PTPI. The last closing price for Petros Pharmaceuticals was US$0.25. Over the last year, Petros Pharmaceuticals shares have traded in a share price range of US$ 0.2208 to US$ 2.27.

Petros Pharmaceuticals currently has 10,014,872 shares in issue. The market capitalisation of Petros Pharmaceuticals is US$2.48 million. Petros Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.19.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.030121	-10.5089996895	0.286621	0.3043	0.2208	175084	0.25918762	CS
4	-0.0736	-22.2962738564	0.3301	0.4299	0.2208	179774	0.32654117	CS
12	-0.1035	-28.75	0.36	0.439	0.2208	174605	0.35123037	CS
26	-0.3925	-60.4776579353	0.649	0.72	0.2208	293226	0.42189533	CS
52	-1.0435	-80.2692307692	1.3	2.27	0.2208	499917	1.04706824	CS
156	-14.0435	-98.2062937063	14.3	52	0.2208	1802051	23.664529	CS
260	-17.7435	-98.575	18	59.599	0.2208	1691139	24.68388939	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
WORXSCWorx Corporation	US$ 2.12 (116.33%)	144.38M
CRNCCerence Inc	US$ 5.83 (106.74%)	77.55M
PROCProcaps Group SA	US$ 1.10 (92.48%)	2.58M
IBGInnovation Beverage Group Limited	US$ 1.19 (50.40%)	12.97M
ARQQArqit Quantum Inc	US$ 10.7599 (46.59%)	900.38k
SKKSKK Holdings Limited	US$ 1.01 (-77.85%)	40.45M
TMTCTMT Acquisition Corporation	US$ 2.20 (-65.84%)	530.14k
WCTWellchange Holdings Company Limited	US$ 1.2596 (-62.06%)	2.34M
TMTCUTMT Acquisition Corporation	US$ 2.89 (-56.74%)	14.07k
GLXGGalaxy Payroll Group Ltd	US$ 1.77 (-54.73%)	2.45M
CDTConduit Pharmaceuticals Inc	US$ 0.1048 (13.54%)	579M
NVDANVIDIA Corporation	US$ 146.67 (0.53%)	401.66M
ELABElevai Labs Inc	US$ 0.020072 (-6.21%)	256.24M
AKTSAkoustis Technologies Inc	US$ 0.1022 (17.34%)	211.19M
MARAMARA Holdings Inc	US$ 24.19 (6.89%)	166.43M